ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 26 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $73,000 | -5.2% | 386,352 | +15.1% | 0.00% | – |
Q1 2022 | $77,000 | -60.5% | 335,573 | +1.5% | 0.00% | – |
Q4 2021 | $195,000 | -34.6% | 330,599 | 0.0% | 0.00% | – |
Q3 2021 | $298,000 | -19.7% | 330,599 | +15.8% | 0.00% | – |
Q2 2021 | $371,000 | +4.2% | 285,567 | +11.4% | 0.00% | – |
Q1 2021 | $356,000 | +204.3% | 256,244 | +178.9% | 0.00% | – |
Q4 2020 | $117,000 | +11.4% | 91,873 | +29.5% | 0.00% | – |
Q3 2020 | $105,000 | -46.7% | 70,949 | -43.2% | 0.00% | – |
Q2 2020 | $197,000 | +89.4% | 124,906 | +15.3% | 0.00% | – |
Q1 2020 | $104,000 | -81.9% | 108,322 | -48.8% | 0.00% | – |
Q4 2019 | $576,000 | +181.0% | 211,708 | +306.1% | 0.00% | – |
Q3 2019 | $205,000 | +20.6% | 52,135 | +24.2% | 0.00% | – |
Q2 2019 | $170,000 | -68.6% | 41,962 | -45.7% | 0.00% | – |
Q1 2019 | $542,000 | -31.2% | 77,245 | -46.6% | 0.00% | – |
Q4 2018 | $788,000 | +9.7% | 144,628 | +116.3% | 0.00% | – |
Q3 2018 | $718,000 | -8.4% | 66,870 | +11.1% | 0.00% | – |
Q2 2018 | $784,000 | +547.9% | 60,182 | +444.7% | 0.00% | – |
Q1 2018 | $121,000 | – | 11,049 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $11,359,000 | 18.32% |
Deer VII & Co. Ltd. | 2,263,365 | $9,212,000 | 8.07% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $13,555,000 | 3.47% |
Partner Investment Management, L.P. | 287,851 | $1,172,000 | 1.24% |
SPHERA FUNDS MANAGEMENT LTD. | 491,193 | $1,999,000 | 0.27% |
PFM Health Sciences, LP | 788,958 | $3,211,000 | 0.06% |
Perceptive Advisors | 132,300 | $538,000 | 0.01% |
Fosun International Ltd | 29,877 | $124,000 | 0.01% |
WEDBUSH SECURITIES INC | 15,400 | $63,000 | 0.01% |
Paloma Partners Management Co | 52,100 | $212,000 | 0.00% |